# Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease

> **NCT01720719** · PHASE4 · UNKNOWN · sponsor: **Xin Gao** · enrollment: 120 (estimated)

## Conditions studied

- Fatty Liver
- Dyslipidemias
- Diabetes Mellitus

## Interventions

- **DRUG:** atorvastatin
- **DRUG:** Vitamin E

## Key facts

- **NCT ID:** NCT01720719
- **Lead sponsor:** Xin Gao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720719, "Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01720719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*